PatientSafe clinches $25M to expand operations, increase sales

By Dave Muoio
Share

PatientSafe Solutions, the San Diego, California-based developer of the PatientTouch workflow-optimizing platform, announced that it has secured $25 million in its latest round of funding. Private investment firm HighBar Partners was the primary contributor, with additional capital coming from the Merck Global Health Innovation Fund, Camden Partners, Psilos Group, and TPG.

PatientTouch is a mobile-friendly platform that consolidates EHR data, communications, clinical workflows, alerts, and customizable care interventions within one app. PatientSafe said it plans to use the $25 million to boost the scale of their operations, increase sales, and explore new options within clinical communications and care delivery.

“The success of PatientSafe highlights the value that an enterprise-grade clinical workflow and communication platform brings to its customers by improving clinician satisfaction, care team productivity, and patient safety in the post-[EHR] era,” John Kim, cofounder and managing partner of HighBar Partners, said in a statement. “We are excited to partner with the PatientSafe team to expand go-to-market capabilities, identify product acquisition opportunities, and continue to foster long-term relationships with leading healthcare organizations throughout the country and internationally.”

In 2016, PatientSafe announced several new hires within its organization. Among these was Si Luo, president and CEO of PatientSafe, who said in a statement that this latest round of funding “strengthens our ability to serve large-scale enterprise customers while continuing to develop and deploy a patient-centric communications and workflow network that unifies the patient, family, and care team across the continuum of care.”

Earlier this year, PatientSafe announced its partnership with Integrating the HealthCare Enterprise (IHE), a consortium of healthcare providers and industry leaders that focuses on computer systems in healthcare. In 2015, the company acquired Merck subsidiary Vree Health to expand its reach outside of the hospital and into the home care market.